Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-10-30
1980-12-23
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125T, A61K 3700, C07C10352
Patent
active
042410517
ABSTRACT:
A method for the treatment of pathological processes in bone and connective tissue comprises the topical application of calcitonin to effect control of said processes by transepithelial action. Preferred compositions for use in the method are ear drops comprising an aprotic solvent or an aqueous medium containing a surface active agent.
REFERENCES:
Gaucher, Revue du Rhumatisme, 1975, 42,595.
Editorial, British Medical Journal, 1977, No. 60741427.
Menzies et al., Acta Otolaryngal 1975, 79, 378.
Solomon et al., BMJ, 1977, 2, 485.
Foster et al., Oral Surgery, 1974, 38, 866.
Yegorov, Oftalmol Zhurnal, 1976, 31, 454.
McDavid, et al., Dental Research, 1977, 56, 540.
Christie Robert B.
Parsons John A.
Rudman Christopher G.
Phillips Delbert R.
Tenenbaum Leon E.
LandOfFree
Calcitonin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcitonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcitonin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2242478